| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2022 | TMCI Treace Medical Concepts, Inc. | Owens Daniel E.52 | Chief Human Resources Officer | Sell | 2,500 | $19.82 | $49,562.00 | -10.5% | +25.4% | -20.8% | |
| Sep 2, 2022 | NVCR Novocure Ltd | Leonard Frank X76 | Chief Development Officer | Sell | 14,796 | $77.50 | $1,146,633.76 | -1.2% | +3.7% | -71.7% | |
| Sep 1, 2022 | DXCM Dexcom Inc | Dolan Matthew Vincent63 | SVP Corporate Strategy-develop | Sell | 5 | $81.63 | $408.15 | - | +40.0% | +22.6% | |
| Sep 1, 2022 | LUNG Pulmonx Corp | Rose Geoffrey Beran81 | Chief Commercial Officer | Sell | 1,027 | $17.89 | $18,372.14 | -0.3% | -67.4% | -44.7% | |
| Sep 1, 2022 | LUNG Pulmonx Corp | Lehman David Aaron79 | General Counsel | Sell | 1,082 | $17.88 | $19,350.08 | -1.2% | -67.4% | -44.7% | |
| Sep 1, 2022 | INGN Inogen Inc | Glezer Stanislav | EVP, Chief Technology Officer | Sell | 1,576 | $28.16 | $44,380.16 | -51.3% | -22.4% | -78.5% | |
| Sep 1, 2022 | OM Outset Medical, Inc. | Ahmed Nabeel84 | Chief Financial Officer | Sell | 87 | $18.05 | $1,570.35 | -0.2% | +19.8% | -21.1% | |
| Sep 1, 2022 | TMDX Transmedics Group, Inc. | Gordon Stephen52 | Chief Financial Officer | Sell | 10,000 | $50.93 | $509,300.00 | -63.6% | +19.2% | +33.2% | |
| Sep 1, 2022 | INGN Inogen Inc | Somer Jason | EVP, Gen. Counsel &Secretary | Sell | 1,145 | $28.16 | $32,243.20 | -49.7% | -22.4% | -78.5% | |
| Sep 1, 2022 | TMDX Transmedics Group, Inc. | Carey John F | VP Of Operations | Sell | 3,000 | $51.09 | $153,268.33 | -48.1% | +19.2% | +33.2% | |
| Sep 1, 2022 | ARAY Accuray Inc | Pervaiz Ali63 | SVP Chief Financial Officer | Sell | 8,069 | $2.38 | $19,204.22 | -4.1% | -14.9% | +21.2% | |
| Sep 1, 2022 | INFU Infusystem Holdings, Inc | Ruiz Thomas Mark46 | Chief Commercial Officer | Sell | 10,000 | $7.60 | $75,950.00 | -23.3% | +10.3% | +32.0% | |
| Sep 1, 2022 | ARAY Accuray Inc | Green Brandon W | VP, Interim CFO | Sell | 10,374 | $2.38 | $24,690.12 | -5.6% | -14.9% | +21.2% | |
| Sep 1, 2022 | LUNG Pulmonx Corp | Sung Derrick81 | Chief Financial Officer | Sell | 1,082 | $17.87 | $19,335.34 | -0.2% | -67.4% | -44.7% | |
| Sep 1, 2022 | TMCI Treace Medical Concepts, Inc. | Treace John T.60 | Chief Executive Offer | Buy | 10,000 | $19.80 | $198,031.00 | +0.2% | +17.4% | -21.0% | |
| Sep 1, 2022 | LUNG Pulmonx Corp | French Glendon E. III84 | President And CEO | Sell | 2,940 | $17.87 | $52,537.80 | -0.1% | -67.4% | -44.7% | |
| Sep 1, 2022 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 2,724 | $3.72 | $10,135.49 | -0.1% | -8.1% | -74.4% | |
| Sep 1, 2022 | RBOT Vicarious Surgical Inc. | Morris June89 | CLO, GC And Secretary | Sell | 900 | $3.72 | $3,348.72 | -0.1% | -8.1% | -74.4% | |
| Sep 1, 2022 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 909 | $3.72 | $3,382.22 | -0.1% | -8.1% | -74.4% | |
| Sep 1, 2022 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | President And CEO | Sell | 3,407 | $3.72 | $12,676.80 | -0.1% | -8.1% | -74.4% | |
| Aug 31, 2022 | EKSO Ekso Bionics Holdings, Inc. | Jones Jason C64 | Senior VP Product Development | Sell | 5,873 | $2.31 | $13,586.60 | -4.5% | -54.0% | -61.7% | |
| Aug 31, 2022 | AHCO Adapthealth Corp. | Williams David Solomon III60 | Director | Sell | 2,254 | $18.19 | $40,993.27 | -12.3% | +19.1% | -33.6% | |
| Aug 31, 2022 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 425 | $23.44 | $9,962.00 | -0.2% | -15.8% | -44.0% | |
| Aug 31, 2022 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality Officer | Sell | 299 | $23.44 | $7,008.56 | -0.3% | -15.8% | -44.0% | |
| Aug 31, 2022 | BLFS Biolife Solutions Inc | Rice Michael72 | CEO | Sell | 906 | $23.44 | $21,236.64 | -0.2% | -15.8% | -44.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.